サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1239491

医療用外骨格（医療用エクソスケルトン）市場：タイプ別、モビリティ別、コンポーネント別、用途別：世界の機会分析と産業予測、2021-2031年

Medical Exoskeleton Market By Type, By Mobility, By Component, By Application : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 264 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
医療用外骨格（医療用エクソスケルトン）市場：タイプ別、モビリティ別、コンポーネント別、用途別：世界の機会分析と産業予測、2021-2031年
出版日: 2023年01月01日
発行: Allied Market Research
ページ情報: 英文 264 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療用外骨格（医療用エクソスケルトン）の世界市場は、2021年に2億3,250万米ドルと評価され、2022年から2031年にかけてCAGR29.4%の成長で、2031年には30億4,470万米ドルに達すると予測されています。

医療用外骨格は、患者が怪我から回復し、歩行リハビリや運動支援のための装具デバイスなど生体能力を高めるために体内に装着する外部フレームとして発達した装着型電気機械機器です。そのため、このフレームは、手足に余分な動き、強さ、持久力を与えます。医療用外骨格は、脊髄損傷（SCI）、神経障害、脳卒中などの外傷、脳性麻痺など、さまざまな病状に苦しむ障害者、傷病者、弱者をサポートするために使用されています。これらの医療用外骨格は、通常、病院やリハビリセンターなどの監視された環境で、医療従事者の監視のもとで使用されます。

医療用外骨格市場の成長は、さまざまな医療用外骨格デバイスの開拓のための技術進歩、脊髄損傷、多発性硬化症、パーキンソン病などの神経疾患の有病率の上昇によって牽引されています。また、障害に苦しむ人々の増加は、医療用外骨格の需要を促進し、市場の成長を促進すると予想されています。例えば、世界保健機関（WHO）によると、2022年12月に、推定13億人、つまり世界人口の16％が重大な障害を経験していると報告されました。この数字は、神経疾患の有病率の増加や老年人口の増加によって増加しています。さらに、脊髄損傷、多発性硬化症、パーキンソン病などの神経疾患を患う人々の増加が、医療用外骨格デバイスの需要を高め、市場成長を後押ししていると考えられています。例えば、National Spinal Cord Injury Model Systems Database（NSCMSD）によると、2022年6月に、約51000人が脊髄損傷に苦しんでいることが報告されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な影響要因
    • 主な投資ポケット
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威が高い
    • 新規参入業者の脅威が高い
    • ライバル意識の高さ
  • 市場力学
    • 促進要因
      • 神経障害の有病率の増加
      • 脊髄損傷および脳損傷の数の増加
      • 高齢者人口の増加
    • 抑制要因
      • 外骨格の医療用途の承認を確保するための規制上の課題
    • 機会
      • 製品承認数の増加： 市場関係者別
      • 主要戦略の採用数の増加：市場関係者別
  • 市場におけるCOVID-19影響分析

第4章 医療用外骨格市場：タイプ別

  • 概要
    • 市場規模と予測
  • パワード外骨格
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • パッシブ外骨格
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第5章 医療用外骨格市場：モビリティ別

  • 概要
    • 市場規模と予測
  • 定置
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • モバイル
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第6章 医療用外骨格市場：コンポーネント別

  • 概要
    • 市場規模と予測
  • ハードウェア
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • ソフトウェア
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第7章 医療用外骨格市場：用途別

  • 概要
    • 市場規模と予測
  • 脊髄損傷
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 脳卒中
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • その他
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第8章 医療用外骨格市場：地域別

  • 概要
    • 市場規模と予測：地域別
  • 北米
    • 主な動向と機会
    • 市場規模と予測：タイプ別
    • 市場規模と予測：モビリティ別
    • 市場規模と予測：コンポーネント別
    • 市場規模と予測：用途別
    • 市場規模と予測：国別
      • 米国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • カナダ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • メキシコ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
  • 欧州
    • 主な動向と機会
    • 市場規模と予測：タイプ別
    • 市場規模と予測：モビリティ別
    • 市場規模と予測：コンポーネント別
    • 市場規模と予測：用途別
    • 市場規模と予測：国別
      • ドイツ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • フランス
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • 英国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • イタリア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • スペイン
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • その他欧州
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
  • アジア太平洋
    • 主な動向と機会
    • 市場規模と予測：タイプ別
    • 市場規模と予測：モビリティ別
    • 市場規模と予測：コンポーネント別
    • 市場規模と予測：用途別
    • 市場規模と予測：国別
      • 日本
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • 中国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • インド
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • オーストラリア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • 韓国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • その他アジア太平洋地域
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
  • ラテンアメリカ・中東・アフリカ
    • 主な動向と機会
    • 市場規模と予測：タイプ別
    • 市場規模と予測：モビリティ別
    • 市場規模と予測：コンポーネント別
    • 市場規模と予測：用途別
    • 市場規模と予測：国別
      • ブラジル
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • サウジアラビア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • 南アフリカ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別
      • その他のラテンアメリカ・中東・アフリカ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：モビリティ別
      • 市場規模と予測：コンポーネント別
      • 市場規模と予測：用途別

第9章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • トップ 10プレーヤーの製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • トッププレーヤーのポジショニング、2021

第10章 企業プロファイル

  • CYBERDYNE INC.
  • Ekso Bionics
  • Ergosante
  • B-Temia
  • ExoAtlet
  • Rewalk Robotics
  • Ottobock SE & Co. KGaA（suit X）
  • Human Motion Technologies LLC
  • Wearable Robotics srl
  • DIH Medical
図表

LIST OF TABLES

  • TABLE 01. GLOBAL MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. MEDICAL EXOSKELETON MARKET FOR POWERED EXOSKELETON, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. MEDICAL EXOSKELETON MARKET FOR PASSIVE EXOSKELETON, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. GLOBAL MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. MEDICAL EXOSKELETON MARKET FOR STATIONARY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. MEDICAL EXOSKELETON MARKET FOR MOBILE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. GLOBAL MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. MEDICAL EXOSKELETON MARKET FOR HARDWARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. MEDICAL EXOSKELETON MARKET FOR SOFTWARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. GLOBAL MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. MEDICAL EXOSKELETON MARKET FOR SPINAL CORD INJURY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. MEDICAL EXOSKELETON MARKET FOR STROKE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. MEDICAL EXOSKELETON MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. MEDICAL EXOSKELETON MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. U.S. MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. U.S. MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. U.S. MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. U.S. MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. CANADA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. CANADA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. CANADA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. CANADA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. MEXICO MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. MEXICO MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. MEXICO MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. MEXICO MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. EUROPE MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. EUROPE MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. EUROPE MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. EUROPE MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. EUROPE MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. GERMANY MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. GERMANY MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. GERMANY MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. GERMANY MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. FRANCE MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. FRANCE MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. FRANCE MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. FRANCE MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. UK MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. UK MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. UK MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. UK MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ITALY MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ITALY MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. ITALY MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. ITALY MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. SPAIN MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. SPAIN MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. SPAIN MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. SPAIN MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. JAPAN MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. JAPAN MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. JAPAN MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. JAPAN MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. CHINA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. CHINA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. CHINA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. CHINA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. INDIA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. INDIA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. INDIA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. INDIA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 90. LAMEA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 91. LAMEA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 92. LAMEA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 93. LAMEA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 94. LAMEA MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 95. BRAZIL MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 96. BRAZIL MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 97. BRAZIL MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 98. BRAZIL MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 99. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 100. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 101. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 102. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 103. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 104. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 105. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 106. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 107. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 108. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 109. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 110. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 111. CYBERDYNE INC.: KEY EXECUTIVES
  • TABLE 112. CYBERDYNE INC.: COMPANY SNAPSHOT
  • TABLE 113. CYBERDYNE INC.: PRODUCT SEGMENTS
  • TABLE 114. CYBERDYNE INC.: PRODUCT PORTFOLIO
  • TABLE 115. CYBERDYNE INC.: KEY STRATERGIES
  • TABLE 116. EKSO BIONICS: KEY EXECUTIVES
  • TABLE 117. EKSO BIONICS: COMPANY SNAPSHOT
  • TABLE 118. EKSO BIONICS: PRODUCT SEGMENTS
  • TABLE 119. EKSO BIONICS: PRODUCT PORTFOLIO
  • TABLE 120. EKSO BIONICS: KEY STRATERGIES
  • TABLE 121. ERGOSANTE: KEY EXECUTIVES
  • TABLE 122. ERGOSANTE: COMPANY SNAPSHOT
  • TABLE 123. ERGOSANTE: PRODUCT SEGMENTS
  • TABLE 124. ERGOSANTE: PRODUCT PORTFOLIO
  • TABLE 125. B-TEMIA: KEY EXECUTIVES
  • TABLE 126. B-TEMIA: COMPANY SNAPSHOT
  • TABLE 127. B-TEMIA: PRODUCT SEGMENTS
  • TABLE 128. B-TEMIA: PRODUCT PORTFOLIO
  • TABLE 129. B-TEMIA: KEY STRATERGIES
  • TABLE 130. EXOATLET: KEY EXECUTIVES
  • TABLE 131. EXOATLET: COMPANY SNAPSHOT
  • TABLE 132. EXOATLET: PRODUCT SEGMENTS
  • TABLE 133. EXOATLET: PRODUCT PORTFOLIO
  • TABLE 134. REWALK ROBOTICS: KEY EXECUTIVES
  • TABLE 135. REWALK ROBOTICS: COMPANY SNAPSHOT
  • TABLE 136. REWALK ROBOTICS: PRODUCT SEGMENTS
  • TABLE 137. REWALK ROBOTICS: PRODUCT PORTFOLIO
  • TABLE 138. REWALK ROBOTICS: KEY STRATERGIES
  • TABLE 139. OTTOBOCK SE & CO. KGAA (SUIT X): KEY EXECUTIVES
  • TABLE 140. OTTOBOCK SE & CO. KGAA (SUIT X): COMPANY SNAPSHOT
  • TABLE 141. OTTOBOCK SE & CO. KGAA (SUIT X): PRODUCT SEGMENTS
  • TABLE 142. OTTOBOCK SE & CO. KGAA (SUIT X): PRODUCT PORTFOLIO
  • TABLE 143. HUMAN MOTION TECHNOLOGIES LLC: KEY EXECUTIVES
  • TABLE 144. HUMAN MOTION TECHNOLOGIES LLC: COMPANY SNAPSHOT
  • TABLE 145. HUMAN MOTION TECHNOLOGIES LLC: PRODUCT SEGMENTS
  • TABLE 146. HUMAN MOTION TECHNOLOGIES LLC: PRODUCT PORTFOLIO
  • TABLE 147. WEARABLE ROBOTICS SRL: KEY EXECUTIVES
  • TABLE 148. WEARABLE ROBOTICS SRL: COMPANY SNAPSHOT
  • TABLE 149. WEARABLE ROBOTICS SRL: PRODUCT SEGMENTS
  • TABLE 150. WEARABLE ROBOTICS SRL: PRODUCT PORTFOLIO
  • TABLE 151. DIH MEDICAL: KEY EXECUTIVES
  • TABLE 152. DIH MEDICAL: COMPANY SNAPSHOT
  • TABLE 153. DIH MEDICAL: PRODUCT SEGMENTS
  • TABLE 154. DIH MEDICAL: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. MEDICAL EXOSKELETON MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF MEDICAL EXOSKELETON MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN MEDICAL EXOSKELETON MARKET (2022-2031)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. HIGH THREAT OF SUBSTITUTES
  • FIGURE 07. HIGH THREAT OF NEW ENTRANTS
  • FIGURE 08. HIGH INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALMEDICAL EXOSKELETON MARKET
  • FIGURE 10. MEDICAL EXOSKELETON MARKET, BY TYPE, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR POWERED EXOSKELETON, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR PASSIVE EXOSKELETON, BY COUNTRY 2021-2031(%)
  • FIGURE 13. MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR STATIONARY, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR MOBILE, BY COUNTRY 2021-2031(%)
  • FIGURE 16. MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR HARDWARE, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR SOFTWARE, BY COUNTRY 2021-2031(%)
  • FIGURE 19. MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR SPINAL CORD INJURY, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR STROKE, BY COUNTRY 2021-2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 23. MEDICAL EXOSKELETON MARKET BY REGION, 2021
  • FIGURE 24. U.S. MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. CANADA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. MEXICO MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. GERMANY MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. FRANCE MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. UK MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. ITALY MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. SPAIN MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. REST OF EUROPE MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. JAPAN MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. CHINA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. INDIA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. AUSTRALIA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. SOUTH KOREA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. BRAZIL MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. REST OF LAMEA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: MEDICAL EXOSKELETON MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2021
  • FIGURE 50. CYBERDYNE INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 51. CYBERDYNE INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 52. EKSO BIONICS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 53. EKSO BIONICS: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 54. EKSO BIONICS: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 55. EKSO BIONICS: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 56. REWALK ROBOTICS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 57. REWALK ROBOTICS: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 58. REWALK ROBOTICS: REVENUE SHARE BY REGION, 2021 (%)
目次
Product Code: A11183

The global medical exoskeleton market was valued at $232.5 million in 2021, and is projected to reach $3,044.7 million by 2031, growing at a CAGR of 29.4% from 2022 to 2031.Medical exoskeleton is a wearable electromechanical device that has been developed as external framework that is worn in the body to help patient recover from an injury and to enhance the biological capabilities such as orthotic devices for gait rehabilitation or locomotion assistance. Therefore, this frame offers limbs extra movement, strength, and endurance. Medical exoskeletons are used to power disabled, injured, or vulnerable people suffering from a variety of medical conditions such as spinal cord injury (SCI), neuropathy, major trauma such as stroke, and cerebral palsy. These medical exoskeletons are typically used in monitored settings such as hospitals and rehab centers under the supervision of medical professionals.

The growth of the medical exoskeleton market is driven by technological advancement for development of different medical exoskeleton devices, and rise in prevalence of spinal cord injuries, neurological disorders such as multiple sclerosis, Parkinson's disease, and others. In addition, increase in number of people suffering from disability is anticipated to fuel the demand for medical exoskeleton and is anticipated to drive the growth of the market. For instance, according to World Health Organization (WHO), in December 2022, it was reported that, an estimated 1.3 billion people - or 16% of the global population experience a significant disability. This number is growing because of an increase prevalence of neurological disorders and rise in number of geriatric populations. Moreover, rise in number of people suffering from spinal cord injuries, neurological disorders such as multiple sclerosis, Parkinson's disease and others is attributed to increase the demand for medical exoskeleton devices and boosts the market growth. For instance, according to National Spinal Cord Injury Model Systems Database (NSCMSD), in June 2022, it was reported that, approximately 51000 people are suffering from spinal cord injury.

In addition, rise in prevalence of neurological disorders such as multiple sclerosis, Parkinson's disease and stroke are anticipated to drive the demand for medical exoskeleton devices and fuels the market growth. For instance, according to National Multiple Sclerosis Society, it was reported that, in September 2020, approximately 2.8 million people worldwide are suffering from multiple sclerosis (MS). As per the same source, it was reported that, nearly 1 million of them are living in the U.S. in 2020.

Moreover, rise in healthcare expenditure, increase in disposable income, and expansion of middle-class population in developing countries are expected to create lucrative growth opportunities to drive the growth of the medical exoskeleton market. In addition, geriatric population is susceptible to neurological disorders and orthopedic diseases. Thus, rise in number of geriatric population is anticipated to fuel the demand for medical exoskeleton devices and drive the market growth. For instance, according to Population Reference Bureau, in 2019, regions such as Asia and Europe are home to some of the world's oldest populations, those ages 65 and above. Top countries include Japan at 28%, followed by Italy at 23%. Finland, Portugal, and Greece round out the top five at just under 22%.

Moreover, rise in expenditure by government to develop healthcare infrastructure fuels the market growth. For instance, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.0% of the gross domestic product (GDP) in 2020, as compared to 9.9% in 2019. Furthermore, it has been estimated that 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment and application used at public health centers, such as hospitals. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for medical exoskeleton application in disabled population, thereby boosting the market growth.

On the other hand, high cost of medical exoskeleton devices and safety concern for devices are some factors that are anticipated to restrain the growth of the medical exoskeleton market.

The medical exoskeleton market is segmented into type, component, mobility, and application. Based on type, the market is divided into powered exoskeleton and passive exoskeleton. Based on component, the market is divided into hardware and software. Based on mobility, the market is bifurcated into stationary and mobile. Based on application, the market is divided into spinal cord injury, stroke, and others. The others segment includes multiple sclerosis, osteoarthritis, Parkinson's disease and acquired brain injuries. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global medical exoskeleton market include: CYBERDYNE INC., Ekso Bionics, Ergosante, B-Temia, ExoAtlet, ReWalk Robotics., Ottobock SE & Co. KGaA (suit X), DIH medical Hocoma., Human Motion Technologies LLC., and Wearable Robotics srl.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical exoskeleton market analysis from 2021 to 2031 to identify the prevailing medical exoskeleton market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the medical exoskeleton market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global medical exoskeleton market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Powered exoskeleton
  • Passive exoskeleton

By Mobility

  • Stationary
  • Mobile

By Component

  • Hardware
  • Software

By Application

  • Spinal Cord Injury
  • Stroke
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • CYBERDYNE INC.
  • Ekso Bionics
  • B-Temia
  • Rewalk Robotics
  • Ottobock SE & Co. KGaA (suit X)
  • DIH Medical
  • Ergosante
  • ExoAtlet
  • Human Motion Technologies LLC
  • Wearable Robotics srl

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. Moderate bargaining power of buyers
    • 3.3.3. High threat of substitutes
    • 3.3.4. High threat of new entrants
    • 3.3.5. High intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the prevalence of neurological disorders.
      • 3.4.1.2. Increase in the number of spinal cord injuries and brain injuries.
      • 3.4.1.3. Rise in the number of geriatric populations.
    • 3.4.2. Restraints
      • 3.4.2.1. Regulatory challenges for securing approvals for medical applications of exoskeletons.
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in the number of product approvals by market players.
      • 3.4.3.2. Rise in the number of adoptions of key strategies by market players
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: MEDICAL EXOSKELETON MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Powered exoskeleton
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Passive exoskeleton
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: MEDICAL EXOSKELETON MARKET, BY MOBILITY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Stationary
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Mobile
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: MEDICAL EXOSKELETON MARKET, BY COMPONENT

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hardware
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Software
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: MEDICAL EXOSKELETON MARKET, BY APPLICATION

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Spinal Cord Injury
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Stroke
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Others
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: MEDICAL EXOSKELETON MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key trends and opportunities
    • 8.2.2. Market size and forecast, by Type
    • 8.2.3. Market size and forecast, by Mobility
    • 8.2.4. Market size and forecast, by Component
    • 8.2.5. Market size and forecast, by Application
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Key market trends, growth factors and opportunities
      • 8.2.6.1.2. Market size and forecast, by Type
      • 8.2.6.1.3. Market size and forecast, by Mobility
      • 8.2.6.1.4. Market size and forecast, by Component
      • 8.2.6.1.5. Market size and forecast, by Application
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Key market trends, growth factors and opportunities
      • 8.2.6.2.2. Market size and forecast, by Type
      • 8.2.6.2.3. Market size and forecast, by Mobility
      • 8.2.6.2.4. Market size and forecast, by Component
      • 8.2.6.2.5. Market size and forecast, by Application
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Key market trends, growth factors and opportunities
      • 8.2.6.3.2. Market size and forecast, by Type
      • 8.2.6.3.3. Market size and forecast, by Mobility
      • 8.2.6.3.4. Market size and forecast, by Component
      • 8.2.6.3.5. Market size and forecast, by Application
  • 8.3. Europe
    • 8.3.1. Key trends and opportunities
    • 8.3.2. Market size and forecast, by Type
    • 8.3.3. Market size and forecast, by Mobility
    • 8.3.4. Market size and forecast, by Component
    • 8.3.5. Market size and forecast, by Application
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Key market trends, growth factors and opportunities
      • 8.3.6.1.2. Market size and forecast, by Type
      • 8.3.6.1.3. Market size and forecast, by Mobility
      • 8.3.6.1.4. Market size and forecast, by Component
      • 8.3.6.1.5. Market size and forecast, by Application
      • 8.3.6.2. France
      • 8.3.6.2.1. Key market trends, growth factors and opportunities
      • 8.3.6.2.2. Market size and forecast, by Type
      • 8.3.6.2.3. Market size and forecast, by Mobility
      • 8.3.6.2.4. Market size and forecast, by Component
      • 8.3.6.2.5. Market size and forecast, by Application
      • 8.3.6.3. UK
      • 8.3.6.3.1. Key market trends, growth factors and opportunities
      • 8.3.6.3.2. Market size and forecast, by Type
      • 8.3.6.3.3. Market size and forecast, by Mobility
      • 8.3.6.3.4. Market size and forecast, by Component
      • 8.3.6.3.5. Market size and forecast, by Application
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Key market trends, growth factors and opportunities
      • 8.3.6.4.2. Market size and forecast, by Type
      • 8.3.6.4.3. Market size and forecast, by Mobility
      • 8.3.6.4.4. Market size and forecast, by Component
      • 8.3.6.4.5. Market size and forecast, by Application
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Key market trends, growth factors and opportunities
      • 8.3.6.5.2. Market size and forecast, by Type
      • 8.3.6.5.3. Market size and forecast, by Mobility
      • 8.3.6.5.4. Market size and forecast, by Component
      • 8.3.6.5.5. Market size and forecast, by Application
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Key market trends, growth factors and opportunities
      • 8.3.6.6.2. Market size and forecast, by Type
      • 8.3.6.6.3. Market size and forecast, by Mobility
      • 8.3.6.6.4. Market size and forecast, by Component
      • 8.3.6.6.5. Market size and forecast, by Application
  • 8.4. Asia-Pacific
    • 8.4.1. Key trends and opportunities
    • 8.4.2. Market size and forecast, by Type
    • 8.4.3. Market size and forecast, by Mobility
    • 8.4.4. Market size and forecast, by Component
    • 8.4.5. Market size and forecast, by Application
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Key market trends, growth factors and opportunities
      • 8.4.6.1.2. Market size and forecast, by Type
      • 8.4.6.1.3. Market size and forecast, by Mobility
      • 8.4.6.1.4. Market size and forecast, by Component
      • 8.4.6.1.5. Market size and forecast, by Application
      • 8.4.6.2. China
      • 8.4.6.2.1. Key market trends, growth factors and opportunities
      • 8.4.6.2.2. Market size and forecast, by Type
      • 8.4.6.2.3. Market size and forecast, by Mobility
      • 8.4.6.2.4. Market size and forecast, by Component
      • 8.4.6.2.5. Market size and forecast, by Application
      • 8.4.6.3. India
      • 8.4.6.3.1. Key market trends, growth factors and opportunities
      • 8.4.6.3.2. Market size and forecast, by Type
      • 8.4.6.3.3. Market size and forecast, by Mobility
      • 8.4.6.3.4. Market size and forecast, by Component
      • 8.4.6.3.5. Market size and forecast, by Application
      • 8.4.6.4. Australia
      • 8.4.6.4.1. Key market trends, growth factors and opportunities
      • 8.4.6.4.2. Market size and forecast, by Type
      • 8.4.6.4.3. Market size and forecast, by Mobility
      • 8.4.6.4.4. Market size and forecast, by Component
      • 8.4.6.4.5. Market size and forecast, by Application
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Key market trends, growth factors and opportunities
      • 8.4.6.5.2. Market size and forecast, by Type
      • 8.4.6.5.3. Market size and forecast, by Mobility
      • 8.4.6.5.4. Market size and forecast, by Component
      • 8.4.6.5.5. Market size and forecast, by Application
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Key market trends, growth factors and opportunities
      • 8.4.6.6.2. Market size and forecast, by Type
      • 8.4.6.6.3. Market size and forecast, by Mobility
      • 8.4.6.6.4. Market size and forecast, by Component
      • 8.4.6.6.5. Market size and forecast, by Application
  • 8.5. LAMEA
    • 8.5.1. Key trends and opportunities
    • 8.5.2. Market size and forecast, by Type
    • 8.5.3. Market size and forecast, by Mobility
    • 8.5.4. Market size and forecast, by Component
    • 8.5.5. Market size and forecast, by Application
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Key market trends, growth factors and opportunities
      • 8.5.6.1.2. Market size and forecast, by Type
      • 8.5.6.1.3. Market size and forecast, by Mobility
      • 8.5.6.1.4. Market size and forecast, by Component
      • 8.5.6.1.5. Market size and forecast, by Application
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Key market trends, growth factors and opportunities
      • 8.5.6.2.2. Market size and forecast, by Type
      • 8.5.6.2.3. Market size and forecast, by Mobility
      • 8.5.6.2.4. Market size and forecast, by Component
      • 8.5.6.2.5. Market size and forecast, by Application
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Key market trends, growth factors and opportunities
      • 8.5.6.3.2. Market size and forecast, by Type
      • 8.5.6.3.3. Market size and forecast, by Mobility
      • 8.5.6.3.4. Market size and forecast, by Component
      • 8.5.6.3.5. Market size and forecast, by Application
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Key market trends, growth factors and opportunities
      • 8.5.6.4.2. Market size and forecast, by Type
      • 8.5.6.4.3. Market size and forecast, by Mobility
      • 8.5.6.4.4. Market size and forecast, by Component
      • 8.5.6.4.5. Market size and forecast, by Application

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top player positioning, 2021

CHAPTER 10: COMPANY PROFILES

  • 10.1. CYBERDYNE INC.
    • 10.1.1. Company overview
    • 10.1.2. Key Executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
    • 10.1.7. Key strategic moves and developments
  • 10.2. Ekso Bionics
    • 10.2.1. Company overview
    • 10.2.2. Key Executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. Ergosante
    • 10.3.1. Company overview
    • 10.3.2. Key Executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
  • 10.4. B-Temia
    • 10.4.1. Company overview
    • 10.4.2. Key Executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Key strategic moves and developments
  • 10.5. ExoAtlet
    • 10.5.1. Company overview
    • 10.5.2. Key Executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
  • 10.6. Rewalk Robotics
    • 10.6.1. Company overview
    • 10.6.2. Key Executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Business performance
    • 10.6.7. Key strategic moves and developments
  • 10.7. Ottobock SE & Co. KGaA (suit X)
    • 10.7.1. Company overview
    • 10.7.2. Key Executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
  • 10.8. Human Motion Technologies LLC
    • 10.8.1. Company overview
    • 10.8.2. Key Executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
  • 10.9. Wearable Robotics srl
    • 10.9.1. Company overview
    • 10.9.2. Key Executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
  • 10.10. DIH Medical
    • 10.10.1. Company overview
    • 10.10.2. Key Executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio